ILMN
$309.88
Illumina
$8.80
2.92%
ILMN
Earnings Whisper ®
N/A
4th Quarter December 2018
Consensus:  $1.35
Revenue:  $856.41 Mil
Tuesday
Jan 22
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when ILMN reports earnings?
Beat
Meet
Miss

Where is ILMN's stock price going from here?
Up
Flat
Down
Stock chart of ILMN
Analysts
Summary of analysts' recommendations for ILMN
Score
Grade
Pivots
Resistance
$324.86
$318.79
$314.34

$308.27

Support
$303.82
$297.75
$293.30
Tweet
Growth
Description
Illumina Inc. is a leading developer of next-generation tools for the large-scale analysis of genetic variation and function. The company's tools will provide information that could be used to improve drugs and therapies, customize diagnoses and treatment, and cure disease. The company is developing a comprehensive line of products that can address the scale of experimentation and the breadth of functional analysis required to achieve the goals of molecular medicine.
Peers
PerkinElmerAgilent TechnologiesCoherentBio-Rad LaboratoriesTranslate BioHarvard Bioscience